Serveur d'exploration sur le thulium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The thulium complex of 1,4,7,10-tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami) as a ParaCEST contrast agent.

Identifieur interne : 000554 ( PubMed/Checkpoint ); précédent : 000553; suivant : 000555

The thulium complex of 1,4,7,10-tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami) as a ParaCEST contrast agent.

Auteurs : Dirk Burdinski ; Johan Lub ; Jeroen A. Pikkemaat ; Sander Langereis ; Holger Grüll ; Wolter Ten Hoeve

Source :

RBID : pubmed:18729087

Descripteurs français

English descriptors

Abstract

1,4,7,10-Tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami), a tetra(1H-imidazol-2-yl) derivative of the well-studied octadentate 1,4,7,10-tetrakis[(carbamoyl)methyl]-1,4,7,10-tetraazacyclododecane (dotam) ligand, was synthesized by reaction of 1,4,7,10-tetraazacyclododecane with N-(1H-imidazol-2-yl)chloroacetamide in high yield. Its tricationic thulium complex was isolated as a water-soluble chloride salt. The detection of the mildly acidic amide and amine protons by direct proton NMR in aqueous solution was unsuccessful, but such exchangeable protons could be detected via their chemical exchange-dependent saturation transfer (CEST) effect. The observed CEST effect was distinctly different from that found for respective dotam complexes and is, therefore, ascribed to exchangeable protons associated with the imidazole substituent.

DOI: 10.1002/cbdv.200890139
PubMed: 18729087


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:18729087

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The thulium complex of 1,4,7,10-tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami) as a ParaCEST contrast agent.</title>
<author>
<name sortKey="Burdinski, Dirk" sort="Burdinski, Dirk" uniqKey="Burdinski D" first="Dirk" last="Burdinski">Dirk Burdinski</name>
<affiliation>
<nlm:affiliation>Department of Bio-Molecular Engineering, Philips Research, High Tech Campus 11, NL-5656 AE Eindhoven. dirk.burdinski@philips.com</nlm:affiliation>
<wicri:noCountry code="subField">NL-5656 AE Eindhoven</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Lub, Johan" sort="Lub, Johan" uniqKey="Lub J" first="Johan" last="Lub">Johan Lub</name>
</author>
<author>
<name sortKey="Pikkemaat, Jeroen A" sort="Pikkemaat, Jeroen A" uniqKey="Pikkemaat J" first="Jeroen A" last="Pikkemaat">Jeroen A. Pikkemaat</name>
</author>
<author>
<name sortKey="Langereis, Sander" sort="Langereis, Sander" uniqKey="Langereis S" first="Sander" last="Langereis">Sander Langereis</name>
</author>
<author>
<name sortKey="Grull, Holger" sort="Grull, Holger" uniqKey="Grull H" first="Holger" last="Grüll">Holger Grüll</name>
</author>
<author>
<name sortKey="Ten Hoeve, Wolter" sort="Ten Hoeve, Wolter" uniqKey="Ten Hoeve W" first="Wolter" last="Ten Hoeve">Wolter Ten Hoeve</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="doi">10.1002/cbdv.200890139</idno>
<idno type="RBID">pubmed:18729087</idno>
<idno type="pmid">18729087</idno>
<idno type="wicri:Area/PubMed/Corpus">000569</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000569</idno>
<idno type="wicri:Area/PubMed/Curation">000569</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000569</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000569</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000569</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The thulium complex of 1,4,7,10-tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami) as a ParaCEST contrast agent.</title>
<author>
<name sortKey="Burdinski, Dirk" sort="Burdinski, Dirk" uniqKey="Burdinski D" first="Dirk" last="Burdinski">Dirk Burdinski</name>
<affiliation>
<nlm:affiliation>Department of Bio-Molecular Engineering, Philips Research, High Tech Campus 11, NL-5656 AE Eindhoven. dirk.burdinski@philips.com</nlm:affiliation>
<wicri:noCountry code="subField">NL-5656 AE Eindhoven</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Lub, Johan" sort="Lub, Johan" uniqKey="Lub J" first="Johan" last="Lub">Johan Lub</name>
</author>
<author>
<name sortKey="Pikkemaat, Jeroen A" sort="Pikkemaat, Jeroen A" uniqKey="Pikkemaat J" first="Jeroen A" last="Pikkemaat">Jeroen A. Pikkemaat</name>
</author>
<author>
<name sortKey="Langereis, Sander" sort="Langereis, Sander" uniqKey="Langereis S" first="Sander" last="Langereis">Sander Langereis</name>
</author>
<author>
<name sortKey="Grull, Holger" sort="Grull, Holger" uniqKey="Grull H" first="Holger" last="Grüll">Holger Grüll</name>
</author>
<author>
<name sortKey="Ten Hoeve, Wolter" sort="Ten Hoeve, Wolter" uniqKey="Ten Hoeve W" first="Wolter" last="Ten Hoeve">Wolter Ten Hoeve</name>
</author>
</analytic>
<series>
<title level="j">Chemistry & biodiversity</title>
<idno type="eISSN">1612-1880</idno>
<imprint>
<date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amides (chemistry)</term>
<term>Amines (chemistry)</term>
<term>Contrast Media (chemical synthesis)</term>
<term>Contrast Media (chemistry)</term>
<term>Hydrogen Bonding</term>
<term>Hydrogen-Ion Concentration</term>
<term>Ligands</term>
<term>Magnetic Resonance Spectroscopy (methods)</term>
<term>Magnetic Resonance Spectroscopy (standards)</term>
<term>Molecular Structure</term>
<term>Organometallic Compounds (chemical synthesis)</term>
<term>Organometallic Compounds (chemistry)</term>
<term>Protons</term>
<term>Reference Standards</term>
<term>Stereoisomerism</term>
<term>Thulium (chemistry)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Amides ()</term>
<term>Amines ()</term>
<term>Composés organométalliques ()</term>
<term>Composés organométalliques (synthèse chimique)</term>
<term>Concentration en ions d'hydrogène</term>
<term>Liaison hydrogène</term>
<term>Ligands</term>
<term>Normes de référence</term>
<term>Produits de contraste ()</term>
<term>Produits de contraste (synthèse chimique)</term>
<term>Protons</term>
<term>Spectroscopie par résonance magnétique ()</term>
<term>Spectroscopie par résonance magnétique (normes)</term>
<term>Structure moléculaire</term>
<term>Stéréoisomérie</term>
<term>Thulium ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en">
<term>Contrast Media</term>
<term>Organometallic Compounds</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Amides</term>
<term>Amines</term>
<term>Contrast Media</term>
<term>Organometallic Compounds</term>
<term>Thulium</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Magnetic Resonance Spectroscopy</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr">
<term>Spectroscopie par résonance magnétique</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en">
<term>Magnetic Resonance Spectroscopy</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr">
<term>Composés organométalliques</term>
<term>Produits de contraste</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Hydrogen Bonding</term>
<term>Hydrogen-Ion Concentration</term>
<term>Ligands</term>
<term>Molecular Structure</term>
<term>Protons</term>
<term>Reference Standards</term>
<term>Stereoisomerism</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Amides</term>
<term>Amines</term>
<term>Composés organométalliques</term>
<term>Concentration en ions d'hydrogène</term>
<term>Liaison hydrogène</term>
<term>Ligands</term>
<term>Normes de référence</term>
<term>Produits de contraste</term>
<term>Protons</term>
<term>Spectroscopie par résonance magnétique</term>
<term>Structure moléculaire</term>
<term>Stéréoisomérie</term>
<term>Thulium</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">1,4,7,10-Tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami), a tetra(1H-imidazol-2-yl) derivative of the well-studied octadentate 1,4,7,10-tetrakis[(carbamoyl)methyl]-1,4,7,10-tetraazacyclododecane (dotam) ligand, was synthesized by reaction of 1,4,7,10-tetraazacyclododecane with N-(1H-imidazol-2-yl)chloroacetamide in high yield. Its tricationic thulium complex was isolated as a water-soluble chloride salt. The detection of the mildly acidic amide and amine protons by direct proton NMR in aqueous solution was unsuccessful, but such exchangeable protons could be detected via their chemical exchange-dependent saturation transfer (CEST) effect. The observed CEST effect was distinctly different from that found for respective dotam complexes and is, therefore, ascribed to exchangeable protons associated with the imidazole substituent.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">18729087</PMID>
<DateCreated>
<Year>2008</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2008</Year>
<Month>12</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1612-1880</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>5</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2008</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Chemistry & biodiversity</Title>
<ISOAbbreviation>Chem. Biodivers.</ISOAbbreviation>
</Journal>
<ArticleTitle>The thulium complex of 1,4,7,10-tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami) as a ParaCEST contrast agent.</ArticleTitle>
<Pagination>
<MedlinePgn>1505-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/cbdv.200890139</ELocationID>
<Abstract>
<AbstractText>1,4,7,10-Tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami), a tetra(1H-imidazol-2-yl) derivative of the well-studied octadentate 1,4,7,10-tetrakis[(carbamoyl)methyl]-1,4,7,10-tetraazacyclododecane (dotam) ligand, was synthesized by reaction of 1,4,7,10-tetraazacyclododecane with N-(1H-imidazol-2-yl)chloroacetamide in high yield. Its tricationic thulium complex was isolated as a water-soluble chloride salt. The detection of the mildly acidic amide and amine protons by direct proton NMR in aqueous solution was unsuccessful, but such exchangeable protons could be detected via their chemical exchange-dependent saturation transfer (CEST) effect. The observed CEST effect was distinctly different from that found for respective dotam complexes and is, therefore, ascribed to exchangeable protons associated with the imidazole substituent.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Burdinski</LastName>
<ForeName>Dirk</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Bio-Molecular Engineering, Philips Research, High Tech Campus 11, NL-5656 AE Eindhoven. dirk.burdinski@philips.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lub</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pikkemaat</LastName>
<ForeName>Jeroen A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Langereis</LastName>
<ForeName>Sander</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Grüll</LastName>
<ForeName>Holger</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>ten Hoeve</LastName>
<ForeName>Wolter</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Chem Biodivers</MedlineTA>
<NlmUniqueID>101197449</NlmUniqueID>
<ISSNLinking>1612-1872</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C533989">(1,4,7,10-tetrakis((N-(1H-imidazol-2-yl)carbamoyl)methyl)-1,4,7,10-tetraazacyclododecane)thulium(III)</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000577">Amides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000588">Amines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008024">Ligands</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009942">Organometallic Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011522">Protons</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>8RKC5ATI4P</RegistryNumber>
<NameOfSubstance UI="D013932">Thulium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000577">Amides</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000588">Amines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000138">chemical synthesis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006860">Hydrogen Bonding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006863">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008024">Ligands</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009682">Magnetic Resonance Spectroscopy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015394">Molecular Structure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009942">Organometallic Compounds</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000138">chemical synthesis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011522">Protons</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012015">Reference Standards</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013237">Stereoisomerism</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013932">Thulium</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2008</Year>
<Month>8</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2008</Year>
<Month>12</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2008</Year>
<Month>8</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="doi">10.1002/cbdv.200890139</ArticleId>
<ArticleId IdType="pubmed">18729087</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Burdinski, Dirk" sort="Burdinski, Dirk" uniqKey="Burdinski D" first="Dirk" last="Burdinski">Dirk Burdinski</name>
<name sortKey="Grull, Holger" sort="Grull, Holger" uniqKey="Grull H" first="Holger" last="Grüll">Holger Grüll</name>
<name sortKey="Langereis, Sander" sort="Langereis, Sander" uniqKey="Langereis S" first="Sander" last="Langereis">Sander Langereis</name>
<name sortKey="Lub, Johan" sort="Lub, Johan" uniqKey="Lub J" first="Johan" last="Lub">Johan Lub</name>
<name sortKey="Pikkemaat, Jeroen A" sort="Pikkemaat, Jeroen A" uniqKey="Pikkemaat J" first="Jeroen A" last="Pikkemaat">Jeroen A. Pikkemaat</name>
<name sortKey="Ten Hoeve, Wolter" sort="Ten Hoeve, Wolter" uniqKey="Ten Hoeve W" first="Wolter" last="Ten Hoeve">Wolter Ten Hoeve</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000554 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000554 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    ThuliumV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:18729087
   |texte=   The thulium complex of 1,4,7,10-tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami) as a ParaCEST contrast agent.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:18729087" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a ThuliumV1 

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu May 12 08:27:09 2016. Site generation: Thu Mar 7 22:33:44 2024